UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020773
Receipt No. R000023862
Scientific Title Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
Date of disclosure of the study information 2016/01/28
Last modified on 2021/02/02 11:37:11

No. Disposal Last modified on Item of update
1 Insert 2016/01/28 09:41:05
2 Update 2016/06/23 14:18:55 Recruitment status
3 Update 2017/01/28 10:24:28 Name of primary sponsor
Organization
4 Update 2019/08/01 09:58:03 Recruitment status
Date of IRB
Last follow-up date
5 Update 2020/01/31 10:24:21 Date of closure to data entry
6 Update 2021/02/02 11:37:11 Recruitment status


Contact us.